Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 151103-09-2
2. 4-(difluoromethoxy)-3-(cyclopropylmethoxy)benzaldehyde
3. 4-(difluoromethoxy)-3-(cyclopropylmethoxy)-benzaldehyde
4. Benzaldehyde, 3-(cyclopropylmethoxy)-4-(difluoromethoxy)-
5. Roflumilast Intermediate A
6. Mfcd07779381
7. 3-(cyclopropylmethoxy)-4-(difluoromethoxy)-benzaldehyde
8. 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde;roflumilast Intermediate
9. Roflumilast Intermediate
10. Schembl832611
11. Dtxsid10597012
12. Bcp07145
13. Zinc59796790
14. Akos015891175
15. Am84469
16. Cs-w006995
17. Ac-29997
18. Ds-14538
19. Sy042624
20. Ft-0660889
21. A24676
22. 3-cyclopropylmethoxy-4difluoromethoxybenzaldehyde
23. 103d092
24. 3-cyclopropylmethoxy 4-difluoromethoxy Benzaldehyde
25. 3-cyclopropylmethoxy-4-difluoromethoxy Benzaldehyde
26. 3-cyclopropylmethoxy-4-difluoromethoxybenzaldehyde
27. A1-00023
28. J-513714
| Molecular Weight | 242.22 g/mol |
|---|---|
| Molecular Formula | C12H12F2O3 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 242.07545056 g/mol |
| Monoisotopic Mass | 242.07545056 g/mol |
| Topological Polar Surface Area | 35.5 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 256 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 151103-09-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 151103-09-2, including repackagers and relabelers. The FDA regulates 151103-09-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 151103-09-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 151103-09-2 supplier is an individual or a company that provides 151103-09-2 active pharmaceutical ingredient (API) or 151103-09-2 finished formulations upon request. The 151103-09-2 suppliers may include 151103-09-2 API manufacturers, exporters, distributors and traders.
151103-09-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 151103-09-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 151103-09-2 GMP manufacturer or 151103-09-2 GMP API supplier for your needs.
A 151103-09-2 CoA (Certificate of Analysis) is a formal document that attests to 151103-09-2's compliance with 151103-09-2 specifications and serves as a tool for batch-level quality control.
151103-09-2 CoA mostly includes findings from lab analyses of a specific batch. For each 151103-09-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
151103-09-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (151103-09-2 EP), 151103-09-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (151103-09-2 USP).
LOOKING FOR A SUPPLIER?
